US 2020/0345841 A1Published application

Compositions and uses

AssigneeGlaxosmithkline Biologicals SA

InventorsDavid BURKHART, Michael COCHRAN, Christopher W. CLUFF, Daniel LAROCQUE, Helene G BAZIN-LEE, Julien ST JEAN

Life of this patent

Estimating the term…

Abstract

The present invention relates to immunogenic compositions and methods for producing them, and in particular, immunogenic compositions comprising a protein antigen cross linked to an oxoadenine adjuvant.

Claims6

Dependent claims

A compound of the formula (I):

wherein X represents OH or NH2.

Dependencies are inferred from the claim text.

Facts

Application: 16/848,910Filed 15 Apr 2020
Priority: 10 Mar 2015
Published: 5 Nov 2020
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 39/39
Medicinal preparations containing antigens or antibodies: characterised by the immunostimulating additives, e.g. chemical adjuvants
A61K 31/52
Ortho- or peri-condensed with heterocyclic rings: purines, e.g. adenine
A61K 31/522
Purines, e.g. adenine: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
A61K 2039/555
Medicinal preparations containing antigens or antibodies: characterised by a specific combination antigen/adjuvant

Family

Application62/130,812Us provisional application · filed 10 Mar 2015
Application15/556,520Continuation · filed 7 Sep 2017
Application16/848,910Continuation
US 10,646,566 B2Related patent
US 11,207,404 B2Related patent
US 2018/0036403 A1Published application
US 2020/0345841 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results